Kaohsiung Journal of Medical Sciences (Nov 2022)
EGFR‐TKI plus antiangiogenic agent combination therapy may reduce the incidence of EGFR‐TKI–associated interstitial lung disease in Asian
Abstract
No abstracts available.
Kaohsiung Journal of Medical Sciences (Nov 2022)